Tokyo, 24 September 2026: SoftBank Group raised $11.1 billion through senior notes in dollars and euros, in what LSEG data cited by Reuters describe as the largest high-yield corporate bond sale on record globally, surpassing Numericable’s $10.9 billion in 2014.
The deal funds Masayoshi Son’s OpenAI bet: SoftBank has committed $64.6 billion and expects to own roughly 13% of the ChatGPT maker “by next week” on the reporting calendar. It is also buying ABB’s robotics business for $5.4 billion and DigitalBridge for $3.1 billion.
The structure: dollar tranches of $1 billion at 3.5 years (8.625%), $4.5 billion at 5.5 years (9.25%) and $4.5 billion at 7.5 years (9.75%); plus two €500 million euro tranches at four and six years (7.125% and 8%). In June 2021 a $7.3 billion SoftBank issue yielded between 2.125% and 5.25%.
The sale follows a ¥1 trillion ($6.3 billion) retail-targeted bond issue the same month. SoftBank has already issued $14.6 billion in high-yield bonds in 2026—63.4% of the Asia-Pacific and Japan high-yield corporate bond market, per Reuters.
Markets applauded demand (“I was positively surprised by the market appetite,” said Fitch’s Satoru Aoyama) but charge a price: the cost of insuring SoftBank debt against default jumped, with the 5-year CDS above 400 basis points versus about 280 in June. CreditSights warns Arm and OpenAI make up three-quarters of the group’s asset value.
IPO plans for OpenAI and data-centre unit SB Energy, once eyed as early as this month, slipped, cutting an expected liquidity path. S&P Global Ratings notes Arm’s strong share price supports SoftBank’s near-term credit quality despite the OpenAI delay.
Macro context: hyperscaler bond sales exceed $200 billion in 2026, more than double year-on-year, and are starting to push global borrowing costs higher. SoftBank shows AI-driven debt issuance has fully reached the high-yield market, not only investment grade.
For OpenAI the signal is ambivalent: it has a sponsor willing to issue near 10% coupons to complete its cheque, but that leverage turns any valuation or safety stumble (Astra cancellation, FTC CIDs, agent incidents) into contagion risk for SoftBank’s balance sheet.
Credit investors must model scenarios: a timely OpenAI IPO (CreditSights sees a possible ratings upgrade) versus prolonged delays, writedowns or regulation that slows agentic deployments. Concentration in two tech assets is the Achilles heel Chapman at CreditSights stresses.
Geopolitically, reliance on Japanese high-yield capital for the most visible U.S. lab complicates White House “self-sufficiency” narratives. Son casts himself as the dominant AI investor; Washington casts a race with China; both need OpenAI not to stumble on safety or markets.
Neural Pulse reads the 24 September issue as the market price of faith in OpenAI—not the equity upside, but the coupon you pay when IPOs slip and CDS spreads widen. It is as much a fixed-income story as an artificial-intelligence one.
The close: while CEOs sign moral pacts on the lawn, SoftBank signs bond prospectuses at 9.75%. One of those signatures carries legal penalties; the other carries default clauses. Neural Pulse readers should track both.
